Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vicini

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Diabetes Care|May 20, 1999
alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetesT Konrad, P Vicini, K Kusterer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 27, 2001
Impact of cyclosporine and low-dose steroid therapy on insulin sensitivity and beta-cell function in patients with long-term liver graftsT Konrad, B Markus, C Allers, et al.
Clinical Pharmacology and Therapeutics|March 20, 2009
Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancyJ S McCune, A Batchelder, K A Guthrie, et al.
International Journal of Impotence Research|December 15, 2015
Minimally invasive infrapubic inflatable penile prosthesis implant for erectile dysfunction: evaluation of efficacy, satisfaction profile and complicationsG Antonini, G M Busetto, E De Berardinis, et al.
Digestion|July 19, 2000
Severity of HCV-induced liver damage alters glucose homeostasis in noncirrhotic patients with chronic HCV infectionT Konrad, S Zeuzem, G Toffolo, et al.
The Journal of Clinical Investigation|August 15, 1997
Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitusT Utriainen, P Nuutila, T Takala, et al.
European Journal of Clinical Investigation|January 29, 2000
Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alphaT Konrad, S Zeuzem, P Vicini, et al.
Circulation|June 17, 1998
Preserved relative dispersion but blunted stimulation of mean flow, absolute dispersion, and blood volume by insulin in skeletal muscle of patients with essential hypertensionH Laine, M J Knuuti, U Ruotsalainen, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 30, 1999
Interferon-alpha improves glucose tolerance in diabetic and non-diabetic patients with HCV-induced liver diseaseT Konrad, P Vicini, S Zeuzem, et al.
British Journal of Pharmacology|March 7, 2014
UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrationsI Hassan-Mohamed, C Giorgio, M Incerti, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Diabetes Care|May 20, 1999
alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetesT Konrad, P Vicini, K Kusterer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 27, 2001
Impact of cyclosporine and low-dose steroid therapy on insulin sensitivity and beta-cell function in patients with long-term liver graftsT Konrad, B Markus, C Allers, et al.
Clinical Pharmacology and Therapeutics|March 20, 2009
Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancyJ S McCune, A Batchelder, K A Guthrie, et al.
International Journal of Impotence Research|December 15, 2015
Minimally invasive infrapubic inflatable penile prosthesis implant for erectile dysfunction: evaluation of efficacy, satisfaction profile and complicationsG Antonini, G M Busetto, E De Berardinis, et al.
Digestion|July 19, 2000
Severity of HCV-induced liver damage alters glucose homeostasis in noncirrhotic patients with chronic HCV infectionT Konrad, S Zeuzem, G Toffolo, et al.
The Journal of Clinical Investigation|August 15, 1997
Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitusT Utriainen, P Nuutila, T Takala, et al.
European Journal of Clinical Investigation|January 29, 2000
Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alphaT Konrad, S Zeuzem, P Vicini, et al.
Circulation|June 17, 1998
Preserved relative dispersion but blunted stimulation of mean flow, absolute dispersion, and blood volume by insulin in skeletal muscle of patients with essential hypertensionH Laine, M J Knuuti, U Ruotsalainen, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 30, 1999
Interferon-alpha improves glucose tolerance in diabetic and non-diabetic patients with HCV-induced liver diseaseT Konrad, P Vicini, S Zeuzem, et al.
British Journal of Pharmacology|March 7, 2014
UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrationsI Hassan-Mohamed, C Giorgio, M Incerti, et al.
Pageof 9